The Journal of Clinical Psychiatry

Page 546

More JCP Articles

Letter to the Editor

Nonalcoholic Steatohepatitis: A Possible Side Effect of Atypical Antipsychotics

July 1, 2003

Egon M. Haberfellner , Thomas Honsig

Article

Noncholinergic Treatment Options for Alzheimer’s Disease

July 1, 2003

Mary Sano

Letter to the Editor

Reply to Olanzapine/Risperidone and Diabetes Risk

July 1, 2003

Frank D. Gianfrancesco

Article

The Search for Better Noncholinergic Treatment Options for Alzheimer’s Disease

July 1, 2003

Jacobo E. Mintzer

Book Review

Beginnings: The Art and Science of Planning Psychotherapy

June 15, 2003

James L. Nash

Book Review

Brain Circuitry and Signaling in Psychiatry: Based Science and Clinical Implications

June 15, 2003

Ronald M. Salomon

Original Research

Chlorpromazine Doses for Antipsychotics

June 15, 2003

Read the full article on Chlorpromazine equivalent doses for the newer atypical antipsychotic medications.

Scott W. Woods

Original Research

Conventional Antipsychotic Prescription in Unipolar Depression, II: Withdrawing Conventional Antipsychotics in Unipolar, Nonpsychotic Patients.

June 15, 2003

Ann M. Mortimer , Maria Martin , Jason A. Wheeler Vega , et al

Original Research

Conventional, Atypical, and Combination Antipsychotic Prescriptions: A 2-Year Comparison

June 15, 2003

Raymond P. Tempier , Nicole H. Pawliuk

Original Research

A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities

June 15, 2003

Catherine S. Fontaine , Linda S. Hynan , Kathleen Koch , et al

Original Research

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder

June 15, 2003

Eric Hollander , Lorrin M. Koran , Wayne K. Goodman , et al

Original Research

Enlargement of Brain Cerebrospinal Fluid Spaces as a Predictor of Poor Clinical Outcome in Melancholia

June 15, 2003

Narcis Cardoner , Jesus Pujol , Julio Vallejo , et al

« 1 … 544 545 546 547 548 … 755 »

Nonalcoholic Steatohepatitis: A Possible Side Effect of Atypical Antipsychotics

Noncholinergic Treatment Options for Alzheimer’s Disease

Reply to Olanzapine/Risperidone and Diabetes Risk

The Search for Better Noncholinergic Treatment Options for Alzheimer’s Disease

Beginnings: The Art and Science of Planning Psychotherapy

Brain Circuitry and Signaling in Psychiatry: Based Science and Clinical Implications

Chlorpromazine Doses for Antipsychotics

Conventional Antipsychotic Prescription in Unipolar Depression, II: Withdrawing Conventional Antipsychotics in Unipolar, Nonpsychotic Patients.

Conventional, Atypical, and Combination Antipsychotic Prescriptions: A 2-Year Comparison

A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder

Enlargement of Brain Cerebrospinal Fluid Spaces as a Predictor of Poor Clinical Outcome in Melancholia

ELSEWHERE:

FOLLOW US:

More JCP Articles

Nonalcoholic Steatohepatitis: A Possible Side Effect of Atypical Antipsychotics

Noncholinergic Treatment Options for Alzheimer’s Disease

Reply to Olanzapine/Risperidone and Diabetes Risk

The Search for Better Noncholinergic Treatment Options for Alzheimer’s Disease

Beginnings: The Art and Science of Planning Psychotherapy

Brain Circuitry and Signaling in Psychiatry: Based Science and Clinical Implications

Chlorpromazine Doses for Antipsychotics

Conventional Antipsychotic Prescription in Unipolar Depression, II: Withdrawing Conventional Antipsychotics in Unipolar, Nonpsychotic Patients.

Conventional, Atypical, and Combination Antipsychotic Prescriptions: A 2-Year Comparison

A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder

Enlargement of Brain Cerebrospinal Fluid Spaces as a Predictor of Poor Clinical Outcome in Melancholia

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles